202 related articles for article (PubMed ID: 27702529)
1. Cisplatin-crosslinked glutathione-sensitive micelles loaded with doxorubicin for combination and targeted therapy of tumors.
Zhang X; Li L; Li C; Zheng H; Song H; Xiong F; Qiu T; Yang J
Carbohydr Polym; 2017 Jan; 155():407-415. PubMed ID: 27702529
[TBL] [Abstract][Full Text] [Related]
2. Glutathione-dependent micelles based on carboxymethyl chitosan for delivery of doxorubicin.
Zhang X; Li C; Zheng H; Song H; Li L; Xiong F; Yang J; Qiu T
J Biomater Sci Polym Ed; 2016 Dec; 27(18):1824-1840. PubMed ID: 27707353
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
Cui C; Xue YN; Wu M; Zhang Y; Yu P; Liu L; Zhuo RX; Huang SW
Biomaterials; 2013 May; 34(15):3858-69. PubMed ID: 23452389
[TBL] [Abstract][Full Text] [Related]
4. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z
Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
[TBL] [Abstract][Full Text] [Related]
5. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
[TBL] [Abstract][Full Text] [Related]
6. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
7. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
8. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
[TBL] [Abstract][Full Text] [Related]
9. Interface cisplatin-crosslinked doxorubicin-loaded triblock copolymer micelles for synergistic cancer therapy.
Gao X; Lu Y; Wu B; Miao J; Chen P; Yang B; Qian J; Si J; Cao M; Xia R
Colloids Surf B Biointerfaces; 2020 Dec; 196():111334. PubMed ID: 32919246
[TBL] [Abstract][Full Text] [Related]
10. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
11. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
12. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging.
Xiong D; Zhang X; Peng S; Gu H; Zhang L
Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801
[TBL] [Abstract][Full Text] [Related]
13. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
Yang S; Tang Z; Zhang D; Deng M; Chen X
Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
[TBL] [Abstract][Full Text] [Related]
14. Reduction-sensitive micelles with sheddable PEG shells self-assembled from a Y-shaped amphiphilic polymer for intracellular doxorubicine release.
Cui C; Yu P; Wu M; Zhang Y; Liu L; Wu B; Wang CX; Zhuo RX; Huang SW
Colloids Surf B Biointerfaces; 2015 May; 129():137-45. PubMed ID: 25843367
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer Therapy.
Wang Z; Wen J; Liu H; Zheng L; Luo H; Liu Z; Chen X; Wang F; Li D; Pei H; Li W; Chen L
J Biomed Nanotechnol; 2018 Jul; 14(7):1225-1238. PubMed ID: 29944097
[TBL] [Abstract][Full Text] [Related]
16. Triggered doxorubicin release using redox-sensitive hyaluronic acid-g-stearic acid micelles for targeted cancer therapy.
Jeong GW; Jeong YI; Nah JW
Carbohydr Polym; 2019 Apr; 209():161-171. PubMed ID: 30732795
[TBL] [Abstract][Full Text] [Related]
17. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.
Yu S; Ding J; He C; Cao Y; Xu W; Chen X
Adv Healthc Mater; 2014 May; 3(5):752-60. PubMed ID: 24574261
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer.
Wang Y; Qian J; Yang M; Xu W; Wang J; Hou G; Ji L; Suo A
Carbohydr Polym; 2019 Dec; 225():115206. PubMed ID: 31521263
[TBL] [Abstract][Full Text] [Related]
19. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin.
Li M; Tang Z; Lv S; Song W; Hong H; Jing X; Zhang Y; Chen X
Biomaterials; 2014 Apr; 35(12):3851-64. PubMed ID: 24495487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]